Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Amazon
AMZN
|
+$597M |
| 2 |
Meta Platforms (Facebook)
META
|
+$497M |
| 3 |
Otis Worldwide
OTIS
|
+$377M |
| 4 |
T-Mobile US
TMUS
|
+$333M |
| 5 |
AbbVie
ABBV
|
+$312M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Apple
AAPL
|
+$457M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$427M |
| 5 |
Accenture
ACN
|
+$245M |
Sector Composition
| 1 | Technology | 23.73% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
LoveSac
LOVE
$258M
| $3.73M | ﹤0.01% |
142,210
+1,230
| +0.9% | +$32.3K |
|
|
CFB
2502
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $3.72M | ﹤0.01% |
380,029
+39,902
| +12% | +$390K |
|
|
CHUY
2503
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $3.69M | ﹤0.01% |
248,181
+944
| +0.4% | +$14K |
|
|
CBAY
2504
DELISTED
Cymabay Therapeutics
CBAY
| $3.69M | ﹤0.01% |
1,056,003
-31,180
| -3% | -$109K |
|
2505
SunCoke Energy
SXC
$654M
| $3.68M | ﹤0.01% |
1,243,486
+97,881
| +9% | +$290K |
|
|
GTT
2506
DELISTED
GTT Communications, Inc.
GTT
| $3.63M | ﹤0.01% |
445,285
+8,882
| +2% | +$72.5K |
|
2507
Forestar Group
FOR
$1.41B
| $3.63M | ﹤0.01% |
240,394
+12,418
| +5% | +$187K |
|
|
VRAY
2508
DELISTED
ViewRay, Inc.
VRAY
| $3.62M | ﹤0.01% |
1,617,127
+36,435
| +2% | +$81.6K |
|
2509
Verastem
VSTM
$598M
| $3.6M | ﹤0.01% |
174,659
+90,887
| +108% | +$1.88M |
|
2510
Blue Bird Corp
BLBD
$1.84B
| $3.59M | ﹤0.01% |
239,502
+5,440
| +2% | +$81.5K |
|
2511
XBiotech
XBIT
$83.8M
| $3.59M | ﹤0.01% |
261,661
-14,997
| -5% | -$206K |
|
2512
Dorian LPG
LPG
$1.35B
| $3.57M | ﹤0.01% |
461,831
+59,773
| +15% | +$463K |
|
2513
Seneca Foods Class A
SENEA
$751M
| $3.57M | ﹤0.01% |
105,534
+1,676
| +2% | +$56.7K |
|
2514
IMAX
IMAX
$1.74B
| $3.56M | ﹤0.01% |
317,559
+3,256
| +1% | +$36.5K |
|
2515
SiTime
SITM
$6.76B
| $3.56M | ﹤0.01% |
75,046
+37,692
| +101% | +$1.79M |
|
|
CNCE
2516
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $3.55M | ﹤0.01% |
356,913
+19,633
| +6% | +$195K |
|
|
RUBY
2517
DELISTED
Rubius Therapeutics, Inc
RUBY
| $3.55M | ﹤0.01% |
593,283
+42,122
| +8% | +$252K |
|
2518
Anavex Life Sciences
AVXL
$805M
| $3.55M | ﹤0.01% |
720,725
+3,144
| +0.4% | +$15.5K |
|
2519
Franklin Covey
FC
$240M
| $3.53M | ﹤0.01% |
164,835
+21,934
| +15% | +$469K |
|
|
BLDP
2520
Ballard Power Systems
BLDP
$622M
| $3.52M | ﹤0.01% |
228,723
+16,379
| +8% | +$252K |
|
2521
Citi Trends
CTRN
$281M
| $3.52M | ﹤0.01% |
174,032
-924
| -0.5% | -$18.7K |
|
2522
Seres Therapeutics
MCRB
$139M
| $3.51M | ﹤0.01% |
36,906
+3,820
| +12% | +$364K |
|
2523
Civista Bancshares
CIVB
$402M
| $3.5M | ﹤0.01% |
227,467
+4,128
| +2% | +$63.6K |
|
2524
KRONOS Worldwide
KRO
$694M
| $3.49M | ﹤0.01% |
335,576
+3,074
| +0.9% | +$32K |
|
2525
Akero Therapeutics
AKRO
$3.48B
| $3.49M | ﹤0.01% |
139,967
+26,060
| +23% | +$649K |
|